VKTX - Viking Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

VKTX - Viking Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#5144()/7023

Fri 03'rd Aug 2018

PERIOD 2018-05-04 - 2018-08-03
CHANGE -4.12%
PRICE $10.25
VOLUME
Sell
TREND
Buy

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

0.00%

Viking Therapeutics Stock Analysis

Technical stock analysis for Fri 03'rd Aug 2018

Sell candidate since 2018-08-03
Shorts 3.41% ( 2018-07-13 )
Cash 21.9 mill
Loans n/a
Beta 2.72
ROA -40.17

Viking Therapeutics fell by -4.12% in the last day from $10.69 to $10.25 The price has risen in 6 of the last 10 days, but is still down by -6.14% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.22 million shares and in total 1.08 million shares bought and sold for approximately $11.09 million.

Trend

Viking Therapeutics lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $10.01 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 72.17% during the next 3 months and, with 90% probability hold a price between $17.23 and $28.35 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Viking Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $10.44 and $10.60. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday August 02, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Viking Therapeutics finds support from accumulated volume at $9.99.

Support: $9.99 Price: $10.25 Resistance: $10.62

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.71 between high and low, or 7.05%. For the last week, the stock has had a daily average volatility of 6.95%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

The Viking Therapeutics stock holds several negative signals and despite the positive trend we believe Viking Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Sell Candidate

Click for Top 5 Sell Candidates
START FREE 5-DAY TRIAL